Changes in gut bacteria may be linked to Parkinson’s disease and can vary with age, disease severity, and medications,…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
A commercially available oral cannabis oil — containing two natural compounds found in the plant, one with psychoactive properties —…
People age 67 and older who lived closer to dry cleaners had higher odds of Parkinson’s disease than those…
An off-the-shelf, or ready to use, stem cell therapy that’s designed to replace the nerve cells lost in Parkinson’s…
Once-daily treatment with tavapadon, an experimental oral small molecule being developed by Abbvie, outperformed a placebo at easing motor…
Gut bacteria that produce vitamin B6 may help nerve cells in the brain produce dopamine, a chemical involved in motor…
Chronic allergic diseases, including asthma and allergic rhinitis (hay fever), may increase the risk of developing Parkinson’s disease by…
A specialized prebiotic supplement can restore healthy gut bacteria in people with Parkinson’s disease, and researchers have discovered a…
A woman diagnosed with early-onset Parkinson’s disease — later found to be caused by a mutation in the VPS13C…
In Parkinson’s disease, toxic clumps of alpha-synuclein protein not only damage brain cells but also weaken the lining of…